#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fibrous dysplasia of bone Systemic sclerosis pulmonary Cushing's syndrome Myotonic dystrophy Inborn error of metabolism Acute lymphocytic leukaemia Uterine leiomyosarcoma Cutaneous T-cell lymphoma recurrent Paget's disease of the vulva Pemphigoid B-cell small lymphocytic lymphoma Pleural mesothelioma malignant Non-small cell lung cancer recurrent Penile cancer Essential thrombocythaemia More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma IgA nephropathy – Trials in Disease Hereditary hypophosphataemic rickets – Life with Disease Paroxysmal nocturnal haemoglobinuria – Life with Disease Marfan’s syndrome – Trials in Disease VEXAS syndrome – Trials in Disease Marfan’s syndrome – Treatment Mastocytosis – Diagnostics Congenital hypotransferrinaemia – Diagnostics Turner’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vinorelbine S-241656 Dinutuximab Beta Fingolimod Abatacept Pantoprazole Prednisolone Sodium Phosphate Cebsulfase Alfa Miransertib Rocatinlimab Adalimumab Ribonucleic Acid K30 Amphotericine B, Liposome Mebeverine Hydrochloride Patritumab Deruxtecan Eptacog Alfa (Activated) Escitalopram Quinapril Hydrochloride Dazucorilant Posaconazole More therapies…

    Learn about Your Condition

    Catatonia Huntington's disease Plasma cell myeloma refractory Acquired ATTR amyloidosis Vitamin D deficiency Procedural pain Metastases to liver Uterine cancer Axial spondyloarthritis Lung cancer metastatic Loeys-Dietz syndrome Essential thrombocythaemia Ocular hypertension Hodgkin's disease refractory Cardiac failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Methylprednisolone and Prednisone for Treating Acute Flare-Ups in Idiopathic Pulmonary Fibrosis Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Methylprednisolone Hydrogen Succinate
    • Prednisone
    • Sodium Chloride
    France

  • Study on the Safety and Effectiveness of Patritumab Deruxtecan for Patients with Colorectal, Biliary Tract, and Liver Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Bile duct cancer
    • Hepatocellular carcinoma
    • Colorectal cancer
    Investigated Drugs:
    • Patritumab Deruxtecan
    France Italy Spain

  • Study of OSE-279 and OSE2101 Drug Combination for Patients with Advanced Solid Tumors, Lymphomas, or Metastatic Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lymphoma
    • Squamous cell carcinoma of lung
    • Neoplasm malignant
    Investigated Drugs:
    • Imsidolimab
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    Belgium France Spain

  • Study Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer metastatic
    Investigated Drugs:
    • Dostarlimab
    • Capecitabine
    • Oxaliplatin
    Belgium Italy Spain

  • Study on Insulin Eye Drops for Treating Persistent Corneal Epithelial Defect in Patients with Neurotrophic or Chronic Ocular Surface Diseases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Persistent corneal epithelial defect
    Investigated Drugs:
    • Insulin Human
    Spain

  • Study on Sclerotherapy for Hydrocele and Spermatocele Using Lauromacrogol 400 and Ethanol in Adult Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hydrocele
    • Spermatocele
    Investigated Drugs:
    • Bupivacaine Hydrochloride
    • Ethanol, Anhydrous
    • Ropivacaine Hydrochloride
    Sweden
Previous Page
1 … 407 408 409 410 411 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!